HRTX
HERON THERAPEUTICS, INC. /DE/
NASDAQ · Healthcare · Biotechnology · US
$0.37
+2.35%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.83x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 10.15x
- Price / sales
- 0.46x
- Price / cash flow
- -6.04x
Enterprise value
- Enterprise value
- $176.9M
- EV / sales
- 1.17x
- EV / EBITDA
- -6.31x
- EV / EBIT
- -16.28x
- Market cap
- $70.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026